Literature DB >> 11350043

DNA-dependent protein kinase is inhibited by trifluoperazine.

A Eriksson1, J Yachnin, R Lewensohn, A Nilsson, A Nilsso.   

Abstract

The DNA-dependent protein kinase (DNA-PK) is a serine/threonine nuclear kinase, important for the repair of DNA double strand breaks (DSB). Cells defective in DNA-PK show increased sensitivity to ionising radiation and different DNA-damaging drugs, such as cisplatinum. Increased sensitivity to cisplatinum has previously been noted in the presence of phenothiazines. We tested a panel of phenothiazines and one thioxanthen for any influence upon the activity and expression of DNA-PK in a nonsmall cell lung cancer cell line, U-1810. The activity of DNA-PK was completely inhibited in cell lysate and in purified enzyme by 200 microM TFP. DNA-PKcs and Ku86 cleavage were evident in U-1810 cells after 30 min incubation with 100 microM TFP, along with changes in the cells consistent with apoptosis. Our study suggests that phenothiazines and thioxanthens, acting through DNA-PK, have the potential to enhance the effects of DNA damaging agents. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350043     DOI: 10.1006/bbrc.2001.4830

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Trifluoperazine and Its Analog Suppressed the Tumorigenicity of Non-Small Cell Lung Cancer Cell; Applicability of Antipsychotic Drugs to Lung Cancer Treatment.

Authors:  Joo Yeon Jeong; Haangik Park; Hong Yoo; Eun-Jin Kim; Borami Jeon; Jong Deog Lee; Dawon Kang; Changjoon Justin Lee; Sun Ha Paek; Eun Joo Roh; Gwan-Su Yi; Sang Soo Kang
Journal:  Biomedicines       Date:  2022-04-30

2.  Liquid Co-crystals of Dual-Active Phenothiazine-NSAID Drugs: Synthesis, Spectroscopic, and Thermal Characterization.

Authors:  Lillian G Pipkin; Brayden C Copeland; Oana Andreea Cojocaru
Journal:  ACS Omega       Date:  2022-05-09

3.  In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation.

Authors:  Ogechi N Ikediobi; Mark Reimers; Steffen Durinck; Paul E Blower; Andrew P Futreal; Michael R Stratton; John N Weinstein
Journal:  Mol Cancer Ther       Date:  2008-06-04       Impact factor: 6.261

4.  Characterization of phenothiazine-induced apoptosis in neuroblastoma and glioma cell lines: clinical relevance and possible application for brain-derived tumors.

Authors:  Irit Gil-Ad; Biana Shtaif; Yechiel Levkovitz; Michal Dayag; Ella Zeldich; Abraham Weizman
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

5.  Phenothiazine Inhibitors of TLKs Affect Double-Strand Break Repair and DNA Damage Response Recovery and Potentiate Tumor Killing with Radiomimetic Therapy.

Authors:  Sharon Ronald; Sanket Awate; Abhijit Rath; Jennifer Carroll; Floyd Galiano; Donard Dwyer; Heather Kleiner-Hancock; J Michael Mathis; Simone Vigod; Arrigo De Benedetti
Journal:  Genes Cancer       Date:  2013-01

6.  Chemosensitization by phenothiazines in human lung cancer cells: impaired resolution of γH2AX and increased oxidative stress elicit apoptosis associated with lysosomal expansion and intense vacuolation.

Authors:  D Zong; P Hååg; I Yakymovych; R Lewensohn; K Viktorsson
Journal:  Cell Death Dis       Date:  2011-07-21       Impact factor: 8.469

Review 7.  The potential of exploiting DNA-repair defects for optimizing lung cancer treatment.

Authors:  Sophie Postel-Vinay; Elsa Vanhecke; Ken A Olaussen; Christopher J Lord; Alan Ashworth; Jean-Charles Soria
Journal:  Nat Rev Clin Oncol       Date:  2012-02-14       Impact factor: 66.675

Review 8.  Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents.

Authors:  David L Brautigan; Caroline Farrington; Goutham Narla
Journal:  Clin Sci (Lond)       Date:  2021-07-16       Impact factor: 6.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.